A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy

A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy

The purpose of this literature review is to comprehensively summarize changes in the expression of phase II drug-metabolizing enzymes and drug transporters in both the pregnant woman and the placenta. Using PubMed<sup>®</sup>, a systematic search was conducted to identify literature rele...

Full description

Bibliographic Details
Main Authors:	Christine Gong, Lynn N. Bertagnolli, David W. Boulton, Paola Coppola
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Pharmaceutics
Subjects:	pregnancy placenta gestational change phase II enzyme drug transporter physiologically based pharmacokinetic (PBPK) modeling
Online Access:	https://www.mdpi.com/1999-4923/15/11/2624

Similar Items

Editorial: Clinical trials in drug metabolism and transport: 2022
by: Yurong Lai, et al.
Published: (2023-06-01)

Utility of Physiologically Based Pharmacokinetic Modeling to Investigate the Impact of Physiological Changes of Pregnancy and Cancer on Oncology Drug Pharmacokinetics
by: Xinxin Yang, et al.
Published: (2023-12-01)

Physiologically Based Pharmacokinetic Modeling in Pregnant Women Suggests Minor Decrease in Maternal Exposure to Olanzapine
by: Liang Zheng, et al.
Published: (2022-01-01)

Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue‐specific drug binding, transport, and metabolism
by: Sandra Witta, et al.
Published: (2023-02-01)

Total and Free Blood and Plasma Concentration Changes in Pregnancy for Medicines Highly Bound to Plasma Proteins: Application of Physiologically Based Pharmacokinetic Modelling to Understand the Impact on Efficacy
by: Paola Coppola, et al.
Published: (2023-10-01)

Microfluidic technology and simulation models in studying pharmacokinetics during pregnancy
by: Ananth K. Kammala, et al.
Published: (2023-08-01)

Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review
by: Sileshi T, et al.
Published: (2022-06-01)

Predictive modelling and simulation for taming the chance and luck in biologics drug discovery
by: Armin Sepp
Published: (2023-10-01)

Challenges Related to Acquisition of Physiological Data for Physiologically Based Pharmacokinetic (PBPK) Models in Postpartum, Lactating Women and Breastfed Infants—A Contribution from the ConcePTION Project
by: Martje Van Neste, et al.
Published: (2023-11-01)

Editorial: Exploring Maternal-Fetal Pharmacology Through PBPK Modeling Approaches
by: André Dallmann, et al.
Published: (2022-05-01)

Development and Application of Physiologically-Based Pharmacokinetic Model to Predict Systemic and Organ Exposure of Colorectal Cancer Drugs
by: Sara Peribañez-Dominguez, et al.
Published: (2025-01-01)

PBPK Modeling of Lamotrigine and Efavirenz during Pregnancy: Implications for Personalized Dosing and Drug-Drug Interaction Management
by: Bárbara Costa, et al.
Published: (2024-09-01)

Imbalance of Drug Transporter-CYP450s Interplay by Diabetes and Its Clinical Significance
by: Yiting Yang, et al.
Published: (2020-04-01)

The Impact of Paediatric Obesity on Drug Pharmacokinetics: A Virtual Clinical Trials Case Study with Amlodipine
by: Khairulanwar Burhanuddin, et al.
Published: (2024-04-01)

High-performance PBPK model for predicting CYP3A4 induction-mediated drug interactions: a refined and validated approach
by: Cheng-Guang Yang, et al.
Published: (2025-02-01)

Immunomodulatory Effects of <i>Atractylodes lancea</i> in Healthy Volunteers with Dosage Prediction for Cholangiocarcinoma Therapy: A Modelling Approach
by: Teerachat Saeheng, et al.
Published: (2025-01-01)

A Physiologically-Based Pharmacokinetic Simulation to Evaluate Approaches to Mitigate Efavirenz-Induced Decrease in Levonorgestrel Exposure with a Contraceptive Implant
by: Lilian W. Adeojo, et al.
Published: (2024-08-01)

Editorial: Insights in drug metabolism and transport: 2021
by: Janny Piñeiro-Llanes, et al.
Published: (2023-05-01)

A Whole-Body Physiologically Based Pharmacokinetic Model Characterizing Interplay of OCTs and MATEs in Intestine, Liver and Kidney to Predict Drug-Drug Interactions of Metformin with Perpetrators
by: Yiting Yang, et al.
Published: (2021-05-01)

A Physiologically-Based Pharmacokinetic (PBPK) Model Network for the Prediction of CYP1A2 and CYP2C19 Drug–Drug–Gene Interactions with Fluvoxamine, Omeprazole, S-mephenytoin, Moclobemide, Tizanidine, Mexiletine, Ethinylestradiol, and Caffeine
by: Tobias Kanacher, et al.
Published: (2020-12-01)

Evaluation of the Drug–Drug Interaction Potential of Cannabidiol Against UGT2B7-Mediated Morphine Metabolism Using Physiologically Based Pharmacokinetic Modeling
by: Shelby Coates, et al.
Published: (2024-12-01)

A systematic review of pregnancy-related clinical intervention of drug regimens due to pharmacokinetic reasons
by: Lauren A. Borda, et al.
Published: (2023-11-01)

An Application of a Physiologically Based Pharmacokinetic Approach to Predict Ceftazidime Pharmacokinetics in a Pregnant Population
by: Khaled Abduljalil, et al.
Published: (2024-03-01)

Application of a Physiologically Based Pharmacokinetic Approach to Predict Theophylline Pharmacokinetics Using Virtual Non-Pregnant, Pregnant, Fetal, Breast-Feeding, and Neonatal Populations
by: Khaled Abduljalil, et al.
Published: (2022-05-01)

Physiologically Based Pharmacokinetic Modelling and Simulation to Predict the Plasma Concentration Profile of Doxorubicin
by: George A. Mystridis, et al.
Published: (2022-02-01)

Yinchenhao Decoction Ameliorates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis in Rats by Regulating Phase II Metabolic Enzymes and Transporters
by: Ya-Xiong Yi, et al.
Published: (2018-05-01)

Prediction of a Therapeutic Dose for Buagafuran, a Potent Anxiolytic Agent by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Starting from Pharmacokinetics in Rats and Human
by: Fen Yang, et al.
Published: (2017-10-01)

Physiologically Based Pharmacokinetic Modelling of UGT Substrate Drugs Lamotrigine and Raltegravir during Pregnancy
by: Monika Berezowska, et al.
Published: (2024-04-01)

Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution
by: Hinojal Zazo, et al.
Published: (2022-02-01)

Phase I clinical trial of NH130 and the prediction of its pharmacokinetics using physiologically based pharmacokinetic modeling
by: Kun Zhang, et al.
Published: (2024-09-01)

Exposure of Infants to Isoniazid via Breast Milk After Maternal Drug Intake of Recommended Doses Is Clinically Insignificant Irrespective of Metaboliser Status. A Physiologically-Based Pharmacokinetic (PBPK) Modelling Approach to Estimate Drug Exposure of Infants via Breast-Feeding
by: Estella Dora Germaine Garessus, et al.
Published: (2019-01-01)

PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Metabolism in Pregnant Subjects and Fetuses
by: Maxime Le Merdy, et al.
Published: (2024-01-01)

Review of the pharmacokinetics of nanodrugs
by: Shao Xiaotong, et al.
Published: (2023-03-01)

Formulation development, characterization, and mechanistic PBPK modeling of metoclopramide loaded halloysite nanotube (HNT) based drug-in-adhesive type transdermal drug delivery system
by: Monica Parkash, et al.
Published: (2024-11-01)

PTH-rP and PTH-R1 Expression in Placentas from Pregnancies Complicated by Gestational Diabetes: New Insights into the Pathophysiology of Hyperglycemia in Pregnancy
by: Angelo Sirico, et al.
Published: (2021-07-01)

Computational Approaches in Preclinical Studies on Drug Discovery and Development
by: Fengxu Wu, et al.
Published: (2020-09-01)

Chemical risk assessment in food animals via physiologically based pharmacokinetic modeling − Part I: Veterinary drugs on human food safety assessment
by: Kun Mi, et al.
Published: (2025-03-01)

Interdisciplinary Collaboration on Real World Data to Close the Knowledge Gap: A Reflection on “De Sutter et al. Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling”
by: Karel Allegaert, et al.
Published: (2024-01-01)

Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling
by: Pieter-Jan De Sutter, et al.
Published: (2023-09-01)

Generic Workflow to Predict Medicine Concentrations in Human Milk Using Physiologically-Based Pharmacokinetic (PBPK) Modelling—A Contribution from the ConcePTION Project
by: Nina Nauwelaerts, et al.
Published: (2023-05-01)